PhecdaMed Co. Ltd has developed the world's first small molecule compound TJ0113, a mitochondrial autophagy inducer with independent intellectual property rights, which has shown great therapeutic potential in preclinical animal models of various diseases.
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar companies
Tired of ads? Enjoy an ad-free experience by signing up.